# Thrasos Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thrasos-therapeutics

- Industry: Biotechnology
- Headquarters: Montreal, Canada
- Total disclosed funding: $56M
- Latest round: Series D (Mar 12, 2015)
- Investors on record: 10

## About

Established in Montreal, Canada, Thrasos Therapeutics Inc. operates as a biotechnology company that focuses on the research and development of targeted therapies for the prevention and treatment of severe organ failure, with a principal focus on kidney disease.

## Funding rounds

- Series D, Mar 12, 2015, $21M — Advanced Technology Ventures, BDC Capital, Pappas Capital, SR One, Fonds de Solidarité des Travailleurs du Québec, GlaxoSmithKline, MP Healthcare Venture Management, Lumira Ventures
- Series C, May 30, 2013 — Pappas Capital
- Series C, Oct 2, 2012, $35M — Advanced Technology Ventures, Pappas Capital, SR One, Fonds de Solidarité des Travailleurs du Québec, MP Healthcare Venture Management, GlaxoSmithKline Plc, SW Co, Lumira Ventures

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series C, Series D
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series C, Series D
- SR One (https://capitalatlas.ai/funds/sr-one) — Series C, Series D
- Fonds de Solidarité des Travailleurs du Québec — Series C, Series D
- MP Healthcare Venture Management (https://capitalatlas.ai/funds/mp-healthcare-venture-management) — Series C, Series D
- GlaxoSmithKline Plc — Series C
- SW Co — Series C
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series C, Series D
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series D
- GlaxoSmithKline — Series D